References
1. Suh-Lailam, B.B., et al., Anti-NMDA-receptor antibody
encephalitis: performance evaluation and laboratory experience with the
anti-NMDA-receptor IgG assay. Clin Chim Acta, 2013. 421 : p.
1-6.
2. Newman, M.P., et al., Autoimmune encephalitis. Intern Med J,
2016. 46 (2): p. 148-57.
3. van Sonderen, A., et al., Anti-LGI1 encephalitis: Clinical
syndrome and long-term follow-up. Neurology, 2016. 87 (14): p.
1449-1456.
4. Sun, L., et al., Creutzfeldt-Jakob disease versus anti-LGI1
limbic encephalitis in a patient with progressive cognitive dysfunction,
psychiatric symptoms, involuntary facio-brachio-crural movement, and an
abnormal electroencephalogram: a case report. Neuropsychiatr Dis Treat,
2015. 11 : p. 1427-30.
5. Oyanguren, B., et al., Limbic encephalitis: a
clinical-radiological comparison between herpetic and autoimmune
etiologies. Eur J Neurol, 2013. 20 (12): p. 1566-70.
6. Ramalho, J. and M. Castillo, Hashimoto’s encephalopathy.Radiol Case Rep, 2011. 6 (1): p. 445.
7. McKeon, A., Autoimmune Encephalopathies and Dementias.Continuum (Minneap Minn), 2016. 22 (2 Dementia): p. 538-58.
8. Kaas, B., et al., Autoimmune limbic encephalitis in association
with acute stroke. Neurol Clin Pract, 2018. 8 (4): p. 349-351.
9. Gultekin, S.H., et al., Paraneoplastic limbic encephalitis:
neurological symptoms, immunological findings and tumour association in
50 patients. Brain, 2000. 123 ( Pt 7) : p. 1481-94.
10. Foster, A.R. and J.P. Caplan, Paraneoplastic limbic
encephalitis. Psychosomatics, 2009. 50 (2): p. 108-13.
11. Florance, N.R., et al., Anti-N-methyl-D-aspartate receptor
(NMDAR) encephalitis in children and adolescents. Ann Neurol, 2009.66 (1): p. 11-8.
12. Irani, S.R. and A. Vincent, The expanding spectrum of
clinically-distinctive, immunotherapy-responsive autoimmune
encephalopathies. Arq Neuropsiquiatr, 2012. 70 (4): p. 300-4.
13. Lai, M., et al., Investigation of LGI1 as the antigen in
limbic encephalitis previously attributed to potassium channels: a case
series. Lancet Neurol, 2010. 9 (8): p. 776-85.
14. Irani, S.R., et al., Antibodies to Kv1 potassium
channel-complex proteins leucine-rich, glioma inactivated 1 protein and
contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome
and acquired neuromyotonia. Brain, 2010. 133 (9): p. 2734-48.
15. Gadoth, A., et al., Expanded phenotypes and outcomes among 256
LGI1/CASPR2-IgG-positive patients. Ann Neurol, 2017. 82 (1): p.
79-92.
16. Hou, T.Y., et al., Correcting abnormalities in miR-124/PTPN1
signaling rescues tau pathology in Alzheimer’s disease. J Neurochem,
2020: p. e14961.
17. Head, K., et al., Defining the expression pattern of the LGI1
gene in BAC transgenic mice. Mamm Genome, 2007. 18 (5): p.
328-37.
18. Frohlich, E. and R. Wahl, Thyroid Autoimmunity: Role of
Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front
Immunol, 2017. 8 : p. 521.
19. Taylor, R.B., et al., Reversible paraneoplastic
encephalomyelitis associated with a benign ovarian teratoma. Can J
Neurol Sci, 1999. 26 (4): p. 317-20.
20. Fadare, O. and H.J. Hart, Anti-Ri antibodies associated with
short-term memory deficits and a mature cystic teratoma of the ovary.Int Semin Surg Oncol, 2004. 1 (1): p. 11.
21. Vitaliani, R., et al., Paraneoplastic encephalitis,
psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann
Neurol, 2005. 58 (4): p. 594-604.
22. Yang, Y.W., et al., Reversible paraneoplastic limbic
encephalitis caused by a benign ovarian teratoma: report of a case and
review of literatures. J Neurooncol, 2006. 80 (3): p. 309-12.
23. Aydiner, A., H. Gurvit, and I. Baral, Paraneoplastic limbic
encephalitis with immature ovarian teratoma–a case report. J
Neurooncol, 1998. 37 (1): p. 63-6.
24. Stein-Wexler, R., et al., Paraneoplastic limbic encephalitis
in a teenage girl with an immature ovarian teratoma. Pediatr Radiol,
2005. 35 (7): p. 694-7.
25. Pestana, I., et al., Paraneoplastic limbic
encephalitis–neurologic paraneoplastic syndrome associated with
ovarian malignancy–the importance of clinical recognition. Eur J
Gynaecol Oncol, 2014. 35 (5): p. 592-4.
26. Iemura, Y., et al., Histopathological characterization of the
neuroglial tissue in ovarian teratoma associated with
anti-N-methyl-D-aspartate (NMDA) receptor encephalitis. Pathol Int,
2018. 68 (12): p. 677-684.
27. Lynch, D.R., et al., Anti-NMDA Receptor Encephalitis: Clinical
Features and Basic Mechanisms. Adv Pharmacol, 2018. 82 : p.
235-260.
28. van Sonderen, A., et al., The value of LGI1, Caspr2 and
voltage-gated potassium channel antibodies in encephalitis. Nat Rev
Neurol, 2017. 13 (5): p. 290-301.
29. Finke, C., et al., Evaluation of Cognitive Deficits and
Structural Hippocampal Damage in Encephalitis With Leucine-Rich,
Glioma-Inactivated 1 Antibodies. JAMA Neurol, 2017. 74 (1): p.
50-59.
30. Li, X., et al., Antibody-LGI 1 autoimmune encephalitis
manifesting as rapidly progressive dementia and hyponatremia: a case
report and literature review. BMC Neurol, 2019. 19 (1): p. 19.
31. Thompson, J., et al., The importance of early immunotherapy in
patients with faciobrachial dystonic seizures. Brain, 2018.141 (2): p. 348-356.
32. Dalmau, J., et al., Anti-NMDA-receptor encephalitis: case
series and analysis of the effects of antibodies. Lancet Neurol, 2008.7 (12): p. 1091-8.
33. Dalmau, J., et al., Clinical experience and laboratory
investigations in patients with anti-NMDAR encephalitis. Lancet Neurol,
2011. 10 (1): p. 63-74.
34. Maureille, A., et al., Isolated seizures are a common early
feature of paraneoplastic anti-GABAB receptor encephalitis. J Neurol,
2019. 266 (1): p. 195-206.
35. Arino, H., et al., Anti-LGI1-associated cognitive impairment:
Presentation and long-term outcome. Neurology, 2016. 87 (8): p.
759-65.
36. Ng, A.C., M. Tripic, and S.M. Mirsattari, Teratoma-negative
anti-NMDA receptor encephalitis presenting with a single generalized
tonic-clonic seizure. Epilepsy Behav Case Rep, 2018. 10 : p.
29-31.
37. Lai, M., et al., AMPA receptor antibodies in limbic
encephalitis alter synaptic receptor location. Ann Neurol, 2009.65 (4): p. 424-34.
38. Petit-Pedrol, M., et al., Encephalitis with refractory
seizures, status epilepticus, and antibodies to the GABAA receptor: a
case series, characterisation of the antigen, and analysis of the
effects of antibodies. Lancet Neurol, 2014. 13 (3): p. 276-86.
39. Chen, X., et al., Encephalitis with antibodies against the
GABAB receptor: seizures as the most common presentation at admission.Neurol Res, 2017. 39 (11): p. 973-980.
40. Wingfield, T., et al., Autoimmune encephalitis: a case series
and comprehensive review of the literature. QJM, 2011.104 (11): p. 921-31.
41. Li, L.H., et al., Clinical and electrographic characteristics
of seizures in LGI1-antibody encephalitis. Epilepsy Behav, 2018.88 : p. 277-282.
42. Hoftberger, R., et al., Encephalitis and GABAB receptor
antibodies: novel findings in a new case series of 20 patients.Neurology, 2013. 81 (17): p. 1500-6.